Annual D&A
Summary
- Current Value
- As of today, RGEN annual D&A is $86.56M, up +0.52% on
- Historical Performance
- RGEN annual D&A is up +125.15% over the past 3 years, and up +314.81% over the past 5 years
- All-Time High Comparison
- RGEN annual D&A is currently at its all-time high
- 3-Year Low Comparison
- RGEN annual D&A is +51.83% above its 3-year low of $57.01M reached on an earlier date
- Sector Comparison
- RGEN annual D&A is higher than 87.86% of companies in Healthcare sector
Depreciation & Amortization Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $86.56M | +0.5% | +125.2% | +314.8% | +6177.2% | |
| Quarterly D&A | $24.41M | +13.8% | +92.6% | +263.7% | +5894.6% | |
| TTM D&A | $94.87M | +7.0% | +99.2% | +269.8% | +6080.1% | |
| Price | $166.82 | +7.8% | +5.0% | -19.9% | +3717.4% | |
| Annual SG&A | $263.37M | +20.5% | +43.2% | +175.4% | +3624.2% | |
| Annual Total Expenses | $666.36M | +8.3% | +34.0% | +184.6% | +2392.2% | |
| Annual Operating Expenses | $306.57M | +17.3% | +40.5% | +166.4% | +1343.9% | |
| Annual Revenue | $634.44M | +0.3% | -5.4% | +134.8% | +2925.3% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $86.56M | at high | |
| 5Y | $86.56M | at high | |
| All | $86.56M | at high |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $57.01M | N/A | +51.8% |
| 5Y | $27.07M | N/A | +219.8% |
| All | $172.40K | >+9999.0% |
Depreciation & Amortization History
FAQ
What is the current annual D&A of RGEN?
As of today, RGEN annual D&A is $86.56M
What is 1-year change in RGEN annual D&A?
RGEN annual D&A is up +0.52% year-over-year
What is 3-year change in RGEN annual D&A?
RGEN annual D&A is up +125.15% over the past 3 years
How far is RGEN annual D&A from its all-time high?
RGEN annual D&A is currently at its all-time high
How does RGEN annual D&A rank versus sector peers?
RGEN annual D&A is higher than 87.86% of companies in Healthcare sector
When is RGEN next annual earnings release?
The next annual earnings release for RGEN is on
Quarterly D&A
Summary
- Current Value
- As of today, RGEN quarterly D&A is $24.41M, down -1.44% on
- Historical Performance
- RGEN quarterly D&A is up +13.77% year-over-year, and up +92.63% over the past 3 years
- All-Time High Comparison
- RGEN quarterly D&A is currently -1.44% below its historical high of $24.77M set on
- 3-Year Low Comparison
- RGEN quarterly D&A is +30.40% above its 3-year low of $18.72M reached on
- Sector Comparison
- RGEN quarterly D&A is higher than 87.72% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $24.41M | -1.4% | +13.8% | +92.6% | +263.7% | |
| Annual D&A | $86.56M | – | +0.5% | +125.2% | +314.8% | |
| TTM D&A | $94.87M | +3.2% | +7.0% | +99.2% | +269.8% | |
| Price | $166.82 | +12.1% | +7.8% | +5.0% | -19.9% | |
| Quarterly SG&A | $73.66M | +3.4% | -2.6% | +37.3% | +153.6% | |
| Quarterly Total Expenses | $173.89M | +3.8% | +11.8% | +8.5% | +118.7% | |
| Quarterly Operating Expenses | $75.84M | +1.7% | +1.6% | +73.0% | +133.5% | |
| Quarterly Revenue | $188.81M | +3.5% | +21.9% | -6.0% | +100.7% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $24.77M | -1.4% | |
| 3Y | $24.77M | -1.4% | |
| 5Y | $24.77M | -1.4% | |
| All | $24.77M | -1.4% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $22.51M | N/A | +8.5% |
| 3Y | $18.72M | +30.4% | |
| 5Y | $7.49M | N/A | +226.1% |
| All | $0.00 | N/A |
Quarterly D&A History
FAQ
What is the current quarterly D&A of RGEN?
As of today, RGEN quarterly D&A is $24.41M
What is RGEN quarterly D&A most recent change?
RGEN quarterly D&A was down -1.44% on September 30, 2025
What is 1-year change in RGEN quarterly D&A?
RGEN quarterly D&A is up +13.77% year-over-year
How far is RGEN quarterly D&A from its all-time high?
RGEN quarterly D&A is currently -1.44% below its historical high of $24.77M set on June 30, 2025
How does RGEN quarterly D&A rank versus sector peers?
RGEN quarterly D&A is higher than 87.72% of companies in Healthcare sector
When is RGEN next earnings release?
The next earnings release for RGEN is on
TTM D&A
Summary
- Current Value
- As of today, RGEN TTM D&A is $94.87M, up +3.21% on
- Historical Performance
- RGEN TTM D&A is up +6.99% year-over-year, and up +99.22% over the past 3 years
- All-Time High Comparison
- RGEN TTM D&A is currently at its all-time high
- 3-Year Low Comparison
- RGEN TTM D&A is +66.41% above its 3-year low of $57.01M reached on an earlier date
- Sector Comparison
- RGEN TTM D&A is higher than 87.62% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $94.87M | +3.2% | +7.0% | +99.2% | +269.8% | |
| Annual D&A | $86.56M | – | +0.5% | +125.2% | +314.8% | |
| Quarterly D&A | $24.41M | -1.4% | +13.8% | +92.6% | +263.7% | |
| Price | $166.82 | +12.1% | +7.8% | +5.0% | -19.9% | |
| TTM SG&A | $1.69B | +507.2% | +549.3% | +688.0% | +1416.2% | |
| TTM Revenue | $707.89M | +5.0% | +11.7% | -11.7% | +116.4% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $94.87M | at high | |
| 3Y | $94.87M | at high | |
| 5Y | $94.87M | at high | |
| All | $94.87M | at high |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $86.56M | N/A | +9.6% |
| 3Y | $57.01M | N/A | +66.4% |
| 5Y | $27.07M | N/A | +250.5% |
| All | $164.20K | >+9999.0% |
TTM D&A History
FAQ
What is the current TTM D&A of RGEN?
As of today, RGEN TTM D&A is $94.87M
What is RGEN TTM D&A most recent change?
RGEN TTM D&A was up +3.21% on September 30, 2025
What is 1-year change in RGEN TTM D&A?
RGEN TTM D&A is up +6.99% year-over-year
How far is RGEN TTM D&A from its all-time high?
RGEN TTM D&A is currently at its all-time high
How does RGEN TTM D&A rank versus sector peers?
RGEN TTM D&A is higher than 87.62% of companies in Healthcare sector
When is RGEN next earnings release?
The next earnings release for RGEN is on
Data Sources & References
- RGEN Official Website www.repligen.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/730272/000119312525252385/0001193125-25-252385-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/730272/000095017025038999/0000950170-25-038999-index.htm
- RGEN Profile on Yahoo Finance finance.yahoo.com/quote/RGEN
- RGEN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rgen
